LGL Partners LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Get Rating) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 3,525 shares of the exchange traded fund’s stock, valued at approximately $317,000.
A number of other large investors have also added to or reduced their stakes in XBI. Norwood Financial Corp grew its holdings in SPDR S&P Biotech ETF by 292.9% during the 1st quarter. Norwood Financial Corp now owns 275 shares of the exchange traded fund’s stock worth $25,000 after acquiring an additional 205 shares in the last quarter. Tortoise Investment Management LLC acquired a new position in SPDR S&P Biotech ETF during the 1st quarter worth $25,000. Integrity Financial Corp WA acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $29,000. MUFG Americas Holdings Corp lifted its position in shares of SPDR S&P Biotech ETF by 73.5% in the 1st quarter. MUFG Americas Holdings Corp now owns 347 shares of the exchange traded fund’s stock worth $31,000 after buying an additional 147 shares during the last quarter. Finally, Concorde Financial Corp bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth about $33,000.
SPDR S&P Biotech ETF Stock Performance
SPDR S&P Biotech ETF stock opened at $88.01 on Friday. The firm’s 50-day moving average is $85.24 and its 200-day moving average is $81.19. SPDR S&P Biotech ETF has a 1 year low of $61.78 and a 1 year high of $134.79.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
- Get a free copy of the StockNews.com research report on SPDR S&P Biotech ETF (XBI)
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
- The Auto Market Is Slowly Recovering, These Stocks May Outperform
- Is DocuSign On The Verge Of A Major Reversal?
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.